SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 897.68 |
| Enterprise Value ($M) | 1,025.59 |
| Book Value ($M) | -49.19 |
| Book Value / Share | -0.21 |
| Price / Book | -18.25 |
| NCAV ($M) | -156.02 |
| NCAV / Share | -0.66 |
| Price / NCAV | -5.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.50 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.21 |
| Current Ratio | 1.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 113.83 |
| Assets | 220.67 |
| Liabilities | 269.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 160.18 |
| Operating Income | -46.21 |
| Net Income | -69.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -40.66 |
| Cash from Investing | -0.03 |
| Cash from Financing | 49.66 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock, Inc. | 6.10 | -0.36 | |
| 13G/A | Satter Muneer A | 2.60 | -64.53 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 719,239 | 4,412,392 | 16.30 | |
| 770,360 | 3,462,643 | 22.25 | |
| 1,147,359 | 4,711,569 | 24.35 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AGEN – Agenus Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. | ALBT – Avalon GloboCare Corp. |
| ALDX – Aldeyra Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io